Annual CFI
-$1300.00
+$700.00+35.00%
31 December 2023
Summary:
ProMIS Neurosciences annual cash flow from investing activities is currently -$1300.00, with the most recent change of +$700.00 (+35.00%) on 31 December 2023. During the last 3 years, it has risen by +$86.40 thousand (+98.52%). PMN annual CFI is now -100.03% below its all-time high of $5.12 million, reached on 01 March 2008.PMN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
ProMIS Neurosciences quarterly cash flow from investing activities is not available.PMN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
ProMIS Neurosciences TTM cash flow from investing activities is not available.PMN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.0% | - | - |
| 3 y3 years | +98.5% | - | - |
| 5 y5 years | -550.0% | - | - |
PMN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.4% | +98.5% | ||||
| 5 y | 5 years | -101.4% | +98.5% | ||||
| alltime | all time | -100.0% | +100.0% |
ProMIS Neurosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$1300.00(-35.0%) | - | - |
| Dec 2022 | -$2000.00(-102.1%) | $0.00(0.0%) | -$2100.00(-102.2%) |
| Sept 2022 | - | $0.00(0.0%) | $93.70 K(+4.0%) |
| June 2022 | - | $0.00(-100.0%) | $90.10 K(-2.6%) |
| Mar 2022 | - | -$2100.00(-102.2%) | $92.50 K(-2.2%) |
| Dec 2021 | $94.60 K(-207.9%) | $95.80 K(-2761.1%) | $94.60 K(-1117.2%) |
| Sept 2021 | - | -$3600.00(-250.0%) | -$9300.00(-89.1%) |
| June 2021 | - | $2400.00(>+9900.0%) | -$85.30 K(-2.7%) |
| Mar 2021 | - | $0.00(-100.0%) | -$87.70 K(0.0%) |
| Dec 2020 | -$87.70 K(>+9900.0%) | -$8100.00(-89.8%) | -$87.70 K(+10.2%) |
| Sept 2020 | - | -$79.60 K(<-9900.0%) | -$79.60 K(<-9900.0%) |
| Dec 2019 | -$200.00(0.0%) | - | - |
| Dec 2018 | -$200.00(0.0%) | - | - |
| Dec 2017 | -$200.00(0.0%) | - | - |
| Dec 2016 | -$200.00(-99.3%) | - | - |
| Dec 2015 | -$29.50 K(+1635.3%) | - | - |
| Dec 2014 | -$1700.00(<-9900.0%) | - | - |
| Mar 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2013 | - | $0.00(-100.0%) | $13.00 K(-85.5%) |
| Mar 2013 | $89.90 K(-82.4%) | $13.00 K(-1400.0%) | $89.90 K(-65.9%) |
| Dec 2012 | - | -$1000.00(-137.0%) | $263.70 K(-58.9%) |
| Sept 2012 | - | $2700.00(-96.4%) | $641.30 K(-20.4%) |
| June 2012 | - | $75.20 K(-59.7%) | $806.00 K(+57.9%) |
| Mar 2012 | $510.30 K | $186.80 K(-50.4%) | $510.40 K(-2.7%) |
| Dec 2011 | - | $376.60 K(+125.0%) | $524.70 K(-60.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $167.40 K(-176.0%) | $1.34 M(-33.1%) |
| June 2011 | - | -$220.40 K(-209.6%) | $2.00 M(-44.6%) |
| Mar 2011 | $3.62 M(<-9900.0%) | $201.10 K(-83.1%) | $3.62 M(+5.4%) |
| Dec 2010 | - | $1.19 M(+43.8%) | $3.43 M(+84.9%) |
| Sept 2010 | - | $830.00 K(-40.4%) | $1.86 M(+46.7%) |
| June 2010 | - | $1.39 M(+8236.5%) | $1.26 M(<-9900.0%) |
| Mar 2010 | -$11.70 K(-100.7%) | $16.70 K(-104.4%) | -$11.60 K(-94.3%) |
| Dec 2009 | - | -$383.20 K(-260.2%) | -$203.60 K(-142.3%) |
| Sept 2009 | - | $239.20 K(+106.7%) | $481.30 K(-73.3%) |
| June 2009 | - | $115.70 K(-166.0%) | $1.80 M(+3.0%) |
| Mar 2009 | $1.75 M(-65.8%) | -$175.30 K(-158.1%) | $1.75 M(-39.8%) |
| Dec 2008 | - | $301.70 K(-80.7%) | $2.91 M(+3.7%) |
| Sept 2008 | - | $1.56 M(+2389.6%) | $2.80 M(-39.5%) |
| June 2008 | - | $62.70 K(-93.6%) | $4.63 M(-9.5%) |
| Mar 2008 | $5.12 M(-182.0%) | $981.80 K(+395.4%) | $5.12 M(-249.9%) |
| Dec 2007 | - | $198.20 K(-94.2%) | -$3.42 M(+20.8%) |
| Sept 2007 | - | $3.39 M(+516.7%) | -$2.83 M(-69.8%) |
| June 2007 | - | $549.70 K(-107.3%) | -$9.37 M(+50.1%) |
| Mar 2007 | -$6.24 M(+36.0%) | -$7.55 M(-1060.6%) | -$6.24 M(+405.9%) |
| Dec 2006 | - | $786.30 K(-124.9%) | -$1.23 M(-21.5%) |
| Sept 2006 | - | -$3.15 M(-185.7%) | -$1.57 M(+123.1%) |
| June 2006 | - | $3.68 M(-244.5%) | -$704.30 K(-84.6%) |
| Mar 2006 | -$4.59 M | -$2.55 M(-666.9%) | -$4.59 M(+124.7%) |
| Dec 2005 | - | $449.00 K(-119.6%) | -$2.04 M(-18.0%) |
| Sept 2005 | - | -$2.29 M(+1020.5%) | -$2.49 M(+1120.5%) |
| June 2005 | - | -$204.10 K | -$204.10 K |
FAQ
- What is ProMIS Neurosciences annual cash flow from investing activities?
- What is the all time high annual CFI for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual CFI year-on-year change?
- What is the all time high quarterly CFI for ProMIS Neurosciences?
- What is the all time high TTM CFI for ProMIS Neurosciences?
What is ProMIS Neurosciences annual cash flow from investing activities?
The current annual CFI of PMN is -$1300.00
What is the all time high annual CFI for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual cash flow from investing activities is $5.12 M
What is ProMIS Neurosciences annual CFI year-on-year change?
Over the past year, PMN annual cash flow from investing activities has changed by +$700.00 (+35.00%)
What is the all time high quarterly CFI for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly cash flow from investing activities is $3.68 M
What is the all time high TTM CFI for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM cash flow from investing activities is $5.12 M